Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380
Last updated 2025-08-14
Summary
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
BrainXpert
sachet/stickpack of 25 g, has no preservatives, no flavors, no sweeteners, and no colorants.
- OTHER
-
Placebo
high-oleic acid sunflower oil as a calorie-equivalent, non-ketogenic vegetable oil, non added vitamin product will also be provided in a powder format in a sachet/stickpack of 25 g.
Sponsors & Collaborators
- collaborator OTHER
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-24
- Primary Completion
- 2027-12-15
- Completion
- 2027-12-15
Countries
- United States
- France
- Germany
- Italy
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
NCT04078178 ·Status: COMPLETED ·Phase: NA
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients
NCT00842920 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI
NCT05594355 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease
NCT03690193 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
NCT06976216 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment
NCT02982642 ·Status: WITHDRAWN ·Phase: PHASE4
-
Lifestyle Intervention Program for Cognitive Impairment
NCT02741804 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Trial of AGB101 for Mild Cognitive Impairment
NCT05986721 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])
NCT01496170 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
NCT00567060 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems
NCT07020494 ·Status: COMPLETED ·Phase: NA
-
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
NCT03369925 ·Status: COMPLETED ·Phase: NA
-
Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
NCT06962501 ·Status: COMPLETED ·Phase: NA
-
Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
NCT00866060 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
NCT04730635 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
NCT03486938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Efficacy of Cognitex
NCT00719953 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Fermented Codonopsis Lanceolata on Improvement in Cognitive-Bio-Markers of Cognitive Functions
NCT03439098 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1